NCI’s Chabner Cautions Against 3-Hour Taxol Infusion, May Lower Response Rate
In Brief: Nobel Prize Awarded To Sharp, Roberts For Gene Splicing; ACS Fills Top Positions
Prostate Cancer Prevention Trial Begins At 222 U.S. Sites
Duke Physician, BM, Patients, Lobby For Reimbursement
Greenpeace Report Says Chemicals Causing Breast Cancers
DCT Board Okays Recompetition of Drug Discovery Groups
NCI Communications Office to contract Media Campaigns
Trending Stories
- Federal judge blocks Trump administration’s move to limit indirect costs to 15% for NIH-funded institutions
The move could gut academic cancer research - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - “Page Not Found:” HHS agencies purge web pages that hint at DEI, health equity, and gender
Medical group sues over removing “information used every day by health professions” - Beyond the $500B Stargate Project: The frontier of AI in oncology beckons
- Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills